These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
572 related items for PubMed ID: 33309643
21. Comparative effectiveness of endoscopic versus microscopic transsphenoidal surgery for patients with growth hormone secreting pituitary adenoma: An emulated trial. Qiao N, Shen M, He W, He M, Zhang Z, Ye H, Shou X, Wang Y, Zhao Y. Clin Neurol Neurosurg; 2021 Aug; 207():106781. PubMed ID: 34246994 [Abstract] [Full Text] [Related]
22. Outcome of Endoscopic Transsphenoidal Surgery for Acromegaly. Kim JH, Hur KY, Lee JH, Lee JH, Se YB, Kim HI, Lee SH, Nam DH, Kim SY, Kim KW, Kong DS, Kim YH. World Neurosurg; 2017 Aug; 104():272-278. PubMed ID: 28465267 [Abstract] [Full Text] [Related]
23. Outcomes of Aggressive Surgical Resection in Growth Hormone-Secreting Pituitary Adenomas with Cavernous Sinus Invasion. Park HH, Kim EH, Ku CR, Lee EJ, Kim SH. World Neurosurg; 2018 Sep; 117():e280-e289. PubMed ID: 29906579 [Abstract] [Full Text] [Related]
25. Long-term endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly. Freda PU, Wardlaw SL, Post KD. J Neurosurg; 1998 Sep; 89(3):353-8. PubMed ID: 9724106 [Abstract] [Full Text] [Related]
26. Efficacy of transsphenoidal surgery in achieving biochemical cure of growth hormone-secreting pituitary adenomas among patients with cavernous sinus invasion: a systematic review and meta-analysis. Briceno V, Zaidi HA, Doucette JA, Onomichi KB, Alreshidi A, Mekary RA, Smith TR. Neurol Res; 2017 May; 39(5):387-398. PubMed ID: 28301972 [Abstract] [Full Text] [Related]
27. Percent reduction of growth hormone levels correlates closely with percent resected tumor volume in acromegaly. Schwyzer L, Starke RM, Jane JA, Oldfield EH. J Neurosurg; 2015 Apr; 122(4):798-802. PubMed ID: 25423276 [Abstract] [Full Text] [Related]
28. Factors influencing the outcome of microsurgical transsphenoidal surgery for pituitary adenomas: a study on 184 patients. Lampropoulos KI, Samonis G, Nomikos P. Hormones (Athens); 2013 Apr; 12(2):254-64. PubMed ID: 23933694 [Abstract] [Full Text] [Related]
33. Short-term preoperative octreotide treatment of GH-secreting pituitary adenoma: predictors of tumor shrinkage. Oshino S, Saitoh Y, Kasayama S, Arita N, Ohnishi T, Kohara H, Izumoto S, Yoshimine T. Endocr J; 2006 Feb; 53(1):125-32. PubMed ID: 16543682 [Abstract] [Full Text] [Related]
34. Age- and Sex-Specific Differences as Predictors of Surgical Remission Among Patients With Acromegaly. Park SH, Ku CR, Moon JH, Kim EH, Kim SH, Lee EJ. J Clin Endocrinol Metab; 2018 Mar 01; 103(3):909-916. PubMed ID: 29272449 [Abstract] [Full Text] [Related]
37. Final Outcome in Growth Hormone-Secreting Adenomas After Combination of Maximal Tumor Resection and Medical Treatment. Torres A, Sanmillan JL, Lau R, Gabarros A. World Neurosurg; 2021 Oct 01; 154():e292-e301. PubMed ID: 34252630 [Abstract] [Full Text] [Related]
38. Results of endoscopic transsphenoidal pituitary surgery in 40 patients with a growth hormone-secreting macroadenoma. Wagenmakers MA, Netea-Maier RT, van Lindert EJ, Pieters GF, Grotenhuis AJ, Hermus AR. Acta Neurochir (Wien); 2011 Jul 01; 153(7):1391-9. PubMed ID: 21347581 [Abstract] [Full Text] [Related]